Pilot Study of DFN-11 Injection in Medication Overuse Headache
Phase of Trial: Phase II
Latest Information Update: 06 Apr 2018
At a glance
- Drugs DFN 11 (Primary)
- Indications Migraine
- Focus Therapeutic Use
- Sponsors Dr Reddys Laboratories
- 11 Jun 2017 Results (n=9) presented at the 59th Annual Scientific Meeting of the American Headache Society
- 07 Jun 2017 According to a Promius Pharma media release data from this study will be presented at the 59th Annual Scientific Meeting of the American Headache Society (AHS).
- 19 Dec 2016 Status changed from recruiting to discontinued.